Warning letter
Health Technology Inc.: warning letter of Nov 15, 2012
FDA warning letter UCM328917 · Atlanta District Office
Key facts
| Reference number | UCM328917 |
|---|---|
| Company | Health Technology Inc. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Nov 15, 2012 |
| Posted date | Nov 15, 2012 |
| Issuing office | Atlanta District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.23, 111, 111.14, 111.75, 111.180, 111.210, 111.15(d)(3), 111.35(b)(1)(i), 111.70(e), 111.140(b)(1), 111.180(b)(3), 111.205(a) and 3 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: